Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis
Eric D. Berglund, … , Yong Xu, Joel K. Elmquist
Eric D. Berglund, … , Yong Xu, Joel K. Elmquist
Published November 1, 2013
Citation Information: J Clin Invest. 2013;123(12):5061-5070. https://doi.org/10.1172/JCI70338.
View: Text | PDF | Corrigendum
Research Article Metabolism

Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis

  • Text
  • PDF
Abstract

Energy and glucose homeostasis are regulated by central serotonin 2C receptors. These receptors are attractive pharmacological targets for the treatment of obesity; however, the identity of the serotonin 2C receptor–expressing neurons that mediate the effects of serotonin and serotonin 2C receptor agonists on energy and glucose homeostasis are unknown. Here, we show that mice lacking serotonin 2C receptors (Htr2c) specifically in pro-opiomelanocortin (POMC) neurons had normal body weight but developed glucoregulatory defects including hyperinsulinemia, hyperglucagonemia, hyperglycemia, and insulin resistance. Moreover, these mice did not show anorectic responses to serotonergic agents that suppress appetite and developed hyperphagia and obesity when they were fed a high-fat/high-sugar diet. A requirement of serotonin 2C receptors in POMC neurons for the maintenance of normal energy and glucose homeostasis was further demonstrated when Htr2c loss was induced in POMC neurons in adult mice using a tamoxifen-inducible POMC-cre system. These data demonstrate that serotonin 2C receptor–expressing POMC neurons are required to control energy and glucose homeostasis and implicate POMC neurons as the target for the effect of serotonin 2C receptor agonists on weight-loss induction and improved glycemic control.

Authors

Eric D. Berglund, Chen Liu, Jong-Woo Sohn, Tiemin Liu, Mi Hwa Kim, Charlotte E. Lee, Claudia R. Vianna, Kevin W. Williams, Yong Xu, Joel K. Elmquist

×

Figure 6

Inducible deletion of serotonin 2C receptors (Htr2c) in POMC neurons of adult mice dysregulates energy homeostasis.

Options: View larger image (or click on image) Download as PowerPoint
Inducible deletion of serotonin 2C receptors (Htr2c) in POMC neurons of ...
Tamoxifen-inducible POMC-cre (POMC-cre:ERT2) mice that coexpress the cre-stimulated fluorescent reporter tdTomato were treated with 0.15 mg/kg tamoxifen (T) i.p. daily for 5 days, and immunohistochemistry was used to assess the expression of Tomato (A and C) and β-endorphin (B and C). Male POMC-cre:ERT2 (C) and 2Cflox/Y x POMC-cre:ERT2 (KO) littermate mice were then treated with tamoxifen or vehicle (V) at 11 weeks of age to assess their chow-fed body weight (D). This was repeated to assess metabolic cages studies in chow-fed mice (E–G; n = 7–9 mice per genotype). Male POMC-cre:ERT2 (WT) and 2Cflox/Y x POMC-cre:ERT2 (2Cflox/Y) littermate mice were also fed an HFHS diet to assess body weight (H). (I–K) Metabolic cage data following 1-week exposure to an HFHS diet (n = 7–9 per genotype). Results are shown as the means ± SEM. *P < 0.05 versus other genotypes using Student’s t tests.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts